Positive effects of short course androgen therapy on the neurodevelopmental outcome in boys with 47,XXY syndrome at 36 and 72 months of age

Authors

Carole A. Samango-Sprouse, George Washington University
Teresa Sadeghin, Texas Children's Hospital
Francie L. Mitchell, Virginia Commonwealth UniversityFollow
Teresa Dixon, Neurodevelopment Diagnostic Center, Crofton, MD
Emily Stapleton, University of VirginiaFollow
Madison Kingery, Focus Foundation, Davidsonville, MD
Andrea L. Gropman, George Washington UniversityFollow

Document Type

Journal Article

Publication Date

3-2013

Journal

American Journal of Medical Genetics, Part A

Volume

Volume 161A, Issue 3

Inclusive Pages

501-508

Keywords

Androgens--administration & dosage; Klinefelter Syndrome--drug therapy; Testosterone--analogs & derivatives

APA Citation

Samango-Sprouse, C. A., Sadeghin, T., Mitchell, F. L., Dixon, T., Stapleton, E., Kingery, M. and Gropman, A. L. (2013), Positive effects of short course androgen therapy on the neurodevelopmental outcome in boys with 47,XXY syndrome at 36 and 72 months of age. Am. J. Med. Genet., 161: 501–508.

Peer Reviewed

1